Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence

被引:9
|
作者
Chan, C. K. [1 ]
Wong, K. H. [2 ]
Lee, M. P. [3 ]
Chan, Kenny C. W. [4 ]
Leung, C. C. [1 ]
Leung, Eric C. C. [1 ]
Chan, W. K. [4 ]
Mak, Ida K. Y. [1 ]
机构
[1] Dept Hlth, TB & Chest Serv, Ctr Hlth Protect, Hong Kong, Hong Kong, Peoples R China
[2] Dept Hlth, Ctr Hlth Protect, Head Off, Hong Kong, Hong Kong, Peoples R China
[3] Hosp Author, Dept Med, Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Dept Hlth, Ctr Hlth Protect, Integrated Treatment Ctr, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; DEATH; DETERMINANTS; ADULTS;
D O I
10.12809/hkmj187303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Data are limited regarding risk factors for mortality among patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) in areas with low HIV prevalence and intermediate TB burden, such as the Western Pacific region. This study aimed to assess such risk factors in Hong Kong, which has an intermediate TB burden and low HIV prevalence. Methods: We conducted a retrospective cohort analysis of adult patients reported to the Hong Kong TB-HIV Registry between 2006 and 2015. Baseline characteristics were compared with Kaplan-Meier estimates. Cox proportional hazards regression modelling was used to identify factors associated with mortality. Results: Of 299 patients studied, 21 (7.0%) died within 12 months of anti-TB treatment (median [interquartile range], 7.5 [3.8-10] months). The median age of death was 54 (interquartile range, 40.5-75.0) years. The cause of death was TB in five and unrelated to TB in the remaining 16. Cox proportional hazards regression showed that older age (adjusted hazard ratio=4.5; 95% confidence interval [CI]=1.4-14.9), history of drug addiction (4.6; 95% CI=1.6-13.0), and low baseline CD4 cell count of <50/mu L (2.9; 95% CI=1.1-7.7) were independent risk factors for death within 12 months. Conclusion: This study complements previous studies by providing information regarding risk factors associated with mortality among patients with HIV-associated TB in areas with intermediate TB burden and low HIV prevalence. The results from our study may guide targeted measures to improve survival in other areas with intermediate TB burden and low HIV prevalence, such as the Western Pacific region.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 50 条
  • [1] Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
    Spies, Ruan
    Schutz, Charlotte
    Ward, Amy
    Balfour, Avuyonke
    Shey, Muki
    Nicol, Mark
    Burton, Rosie
    Sossen, Bianca
    Wilkinson, Robert
    Barr, David
    Meintjes, Graeme
    [J]. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2022, 23 (01)
  • [2] Prevalence and associated risk factors for tuberculosis among people living with HIV in Nepal
    Adhikari, Nilaramba
    Bhattarai, Ratna Bahadur
    Basnet, Rajendra
    Joshi, Lok Raj
    Tinkari, Bhim Singh
    Thapa, Anil
    Joshi, Basant
    [J]. PLOS ONE, 2022, 17 (01):
  • [3] Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya
    Onyango, Dickens O.
    Yuen, Courtney M.
    Cain, Kevin P.
    Ngari, Faith
    Masini, Enos O.
    Borgdorff, Martien W.
    [J]. PLOS ONE, 2017, 12 (11):
  • [4] HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death
    Kingkaew, Nara
    Sangtong, Burachat
    Amnuaiphon, Waraya
    Jongpaibulpatana, Jessada
    Mankatittham, Wiroj
    Akksilp, Somsak
    Sirinak, Chawin
    Nateniyom, Sriprapa
    Burapat, Channawong
    Kittikraisak, Wanitchaya
    Monkongdee, Patama
    Varma, Jay K.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 722 - 729
  • [5] Relationship Between Blood Concentrations of Hepcidin and Anemia Severity, Mycobacterial Burden, and Mortality Among Patients With HIV-Associated Tuberculosis
    Kerkhoff, Andrew D.
    Meintjes, Graeme
    Burton, Rosie
    Vogt, Monica
    Wood, Robin
    Lawn, Stephen D.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (01): : 61 - 70
  • [6] Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death
    Rutakingirwa, Morris K.
    Cresswell, Fiona V.
    Kwizera, Richard
    Ssebambulidde, Kenneth
    Kagimu, Enock
    Nuwagira, Edwin
    Tugume, Lillian
    Mpoza, Edward
    Dobbin, Joanna
    Williams, Darlisha A.
    Muzoora, Conrad
    Meya, David B.
    Boulware, David R.
    Hullsiek, Kathy H.
    Rhein, Joshua
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [7] Antiretroviral therapy among patients with HIV in Almaty, Kazakhstan: the implication for HIV-associated tuberculosis control
    Denebayeva, Alfiya
    Abrahamyan, Arpine
    Sargsyan, Aelita
    Kentenyants, Karine
    Zhandybayeva, Ainur
    Nugmanova, Zhamilya
    Nurkerimova, Anarkhan
    Davtyan, Karapet
    Tukeyev, Marat
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (11): : 128S - 132S
  • [8] Mortality predictors among patients with HIV-associated pulmonary tuberculosis in Northeast China: A retrospective cohort analysis
    Wu, Yongfeng
    Yang, Yang
    Wei, Huaying
    Jia, Lin
    Jiang, Taiyi
    Tian, Yakun
    Guo, Caiping
    Zhang, Yulin
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (08) : 4901 - 4907
  • [9] Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?
    Jarvis, Joseph N.
    Harrison, Thomas S.
    Corbett, Elizabeth L.
    Wood, Robin
    Lawn, Stephen D.
    [J]. AIDS, 2010, 24 (04) : 612 - 614
  • [10] HIV-associated osteoporosis in Ireland: prevalence and risk factors
    Chew, Nicholas S.
    Sheehan, Gerard S.
    Lambert, John
    McConkey, Samuel J.
    Cotter, Eoin J.
    Doran, Peter P.
    Powderly, William G.
    [J]. FUTURE VIROLOGY, 2012, 7 (08) : 791 - 799